Nuvation Bio
NUVB
NUVB
161 hedge funds and large institutions have $365M invested in Nuvation Bio in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.19%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
23
Increased
53
Reduced
52
Closed
18
Calls
$10K
Puts
$899K
Net Calls
-$889K
Net Calls Change
+$60K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$89.1M |
| 2 |
LCM
Laurion Capital Management
New York
|
$17.4M |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
$4.31M |
| 4 |
Millennium Management
New York
|
$6.64M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
$4.39M |
Top Sellers
| 1 |
OCA
Octagon Capital Advisors
New York
|
$13.9M |
| 2 |
SCM
Sio Capital Management
New York
|
$0 |
| 3 |
Goldman Sachs
New York
|
$1.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$1.53M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
$238K |
